Questa Capital beats $300m goal for sophomore fundraise
Healthcare-focused venture capital house Questa Capital has beaten its initial $300m target for its sophomore fundraise.
Healthcare-focused venture capital house Questa Capital has beaten its initial $300m target for its sophomore fundraise.
Former KKR dealmaker Jim Momtazee has reportedly launched his own private equity house targeting investments in the burgeoning healthcare sector.
One Equity Partners has picked up advanced wound care and medical procedure supplies and services company American Medical Technologies.
Europe's Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.
Arsenal Capital Partners has completed a £181.8m buyout of healthcare-focused advisory firm Cello Health.
Global private equity giant Blackstone has brought in former Pfizer CEO and chairman Jeffrey Kindler as its latest senior advisor.
Industrials and healthcare-focused private equity firm Arsenal Capital Partners has brought in veteran Sun Capital managing director Aaron Wolfe as a new investment partner.
European life science and healthcare investor LSP has led a €32m Series B financing round for VarmX, a biotech company focused on developing approaches for the reversal of anticoagulation.
Online health insurance platform Oscar has closed a new funding round on $225m as it looks to continue its growth.
Life sciences-focused private equity house Aisling Capital has raised more than $144m towards its latest flagship fundraise.
Cedar, a FinTech company hoping to simplify the financial experience for patients, has netted $102m in a Series C round led by Andreessen Horowitz.
Healthcare-focused private equity firm Grant Avenue Capital has brought in experienced investor Preston Brice as its newest partner.
Financial services-focused private equity house Lightyear Capital has agreed to buy an indirect controlling stake in digital insurance broker Health Plan One.
Swiss contract research, development and manufacturing specialist Solvias has been bought by JLL Partners and Water Street Partners.
Life sciences venture capital firm Sofinnova Partners has sold its portfolio company Corvidia Therapeutics to Novo Nordisk for $2.1bn.
Middle-market private equity firm Kian Capital Partners has successfully exited TrueLearn, a provider of virtual learning and exam preparation technology for physicians and healthcare professionals.